645 related articles for article (PubMed ID: 34981359)
1. Opioid Use Disorder Treatment Initiation and Continuation: a Qualitative Study of Patients Who Received Addiction Consultation and Hospital-Based Providers.
Calcaterra SL; Lockhart S; Callister C; Hoover K; Binswanger IA
J Gen Intern Med; 2022 Aug; 37(11):2786-2794. PubMed ID: 34981359
[TBL] [Abstract][Full Text] [Related]
2. Experiences with an addiction consultation service on care provided to hospitalized patients with opioid use disorder: a qualitative study of hospitalists, nurses, pharmacists, and social workers.
Callister C; Lockhart S; Holtrop JS; Hoover K; Calcaterra SL
Subst Abus; 2022; 43(1):615-622. PubMed ID: 34666634
[No Abstract] [Full Text] [Related]
3. Management of opioid withdrawal and initiation of medications for opioid use disorder in the hospital setting.
Carswell N; Angermaier G; Castaneda C; Delgado F
Hosp Pract (1995); 2022 Oct; 50(4):251-258. PubMed ID: 35837678
[TBL] [Abstract][Full Text] [Related]
4. Caring for Hospitalized Adults With Opioid Use Disorder in the Era of Fentanyl: A Review.
Englander H; Thakrar AP; Bagley SM; Rolley T; Dong K; Hyshka E
JAMA Intern Med; 2024 Jun; 184(6):691-701. PubMed ID: 38683591
[TBL] [Abstract][Full Text] [Related]
5. Barriers to initiate buprenorphine and methadone for opioid use disorder treatment with postdischarge treatment linkage.
Calcaterra SL; Lockhart S; Natvig C; Mikulich S
J Hosp Med; 2023 Oct; 18(10):896-907. PubMed ID: 37608527
[TBL] [Abstract][Full Text] [Related]
6. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
Velasquez M; Flannery M; Badolato R; Vittitow A; McDonald RD; Tofighi B; Garment AR; Giftos J; Lee JD
Addict Sci Clin Pract; 2019 Oct; 14(1):37. PubMed ID: 31570100
[TBL] [Abstract][Full Text] [Related]
7. "Now hospital leaders are paying attention": A qualitative study of internal and external factors influencing addiction consult services.
Priest KC; Englander H; McCarty D
J Subst Abuse Treat; 2020 Mar; 110():59-65. PubMed ID: 31952629
[TBL] [Abstract][Full Text] [Related]
8. Uptake of slow-release oral morphine as opioid agonist treatment among hospitalised patients with opioid use disorder.
Brothers TD; Fraser J; MacAdam E; Morgan B; Webster D
Drug Alcohol Rev; 2022 Feb; 41(2):430-434. PubMed ID: 34347327
[TBL] [Abstract][Full Text] [Related]
9. Patient Barriers and Facilitators to Medications for Opioid Use Disorder in Primary Care.
Tofighi B; Williams AR; Chemi C; Suhail-Sindhu S; Dickson V; Lee JD
Subst Use Misuse; 2019; 54(14):2409-2419. PubMed ID: 31429351
[No Abstract] [Full Text] [Related]
10. Unintended consequences of methadone regulation for opioid use disorder treatment among hospitalized patients.
Calcaterra SL; Dafoe A; Tietbohl C; Thurman L; Bredenberg E
J Hosp Med; 2024 Jun; 19(6):460-467. PubMed ID: 38507276
[TBL] [Abstract][Full Text] [Related]
11. OUD MEETS: A novel program to increase initiation of medications for opioid use disorder and improve outcomes for hospitalized patients being discharged to skilled nursing facilities.
Tassey TE; Ott GE; Alvanzo AAH; Peirce JM; Antoine D; Buresh ME
J Subst Abuse Treat; 2022 Dec; 143():108895. PubMed ID: 36215913
[TBL] [Abstract][Full Text] [Related]
12. Contextual barriers and enablers to establishing an addiction-focused consultation team for hospitalized adults with opioid use disorder.
Evans SK; Ober AJ; Korn AR; Peltz A; Friedmann PD; Page K; Murray-Krezan C; Huerta S; Ryzewicz SJ; Tarhuni L; Nuckols TK; E Watkins K; Danovitch I
Addict Sci Clin Pract; 2024 Apr; 19(1):31. PubMed ID: 38671482
[TBL] [Abstract][Full Text] [Related]
13. Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use disorder.
Bart G; Korthuis PT; Donohue JM; Hagedorn HJ; Gustafson DH; Bazzi AR; Enns E; McNeely J; Ghitza UE; Magane KM; Baukol P; Vena A; Harris J; Voronca D; Saitz R
Addict Sci Clin Pract; 2024 Apr; 19(1):29. PubMed ID: 38600571
[TBL] [Abstract][Full Text] [Related]
14. Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings.
Frost MC; Soyer EM; Achtmeyer CE; Hawkins EJ; Glass JE; Hallgren KA; Williams EC
Addict Sci Clin Pract; 2023 May; 18(1):26. PubMed ID: 37143162
[TBL] [Abstract][Full Text] [Related]
15. Opioid-induced analgesia among persons with opioid use disorder receiving methadone or buprenorphine: A systematic review of experimental pain studies.
De Aquino JP; Parida S; Avila-Quintero VJ; Flores J; Compton P; Hickey T; Gómez O; Sofuoglu M
Drug Alcohol Depend; 2021 Nov; 228():109097. PubMed ID: 34601272
[TBL] [Abstract][Full Text] [Related]
16. Low-dose buprenorphine initiation and treatment continuation among hospitalized patients with opioid dependence: A retrospective cohort study.
Hayes BT; Li P; Nienaltow T; Torres-Lockhart K; Khalid L; Fox AD
J Subst Use Addict Treat; 2024 Mar; 158():209261. PubMed ID: 38103838
[TBL] [Abstract][Full Text] [Related]
17. "Get in and get out, get on with life": Patient and provider perspectives on methadone van implementation for opioid use disorder treatment.
Suen LW; Steiger S; Shapiro B; Castellanos S; Joshi N; Lambdin BH; Knight KR
Int J Drug Policy; 2023 Nov; 121():104214. PubMed ID: 37778132
[TBL] [Abstract][Full Text] [Related]
18. Initiation of opioid agonist therapy after hospital visits for opioid poisonings in Ontario.
Hu T; McCormack D; Juurlink DN; Campbell TJ; Bayoumi AM; Leece P; Kent JT; Gomes T
CMAJ; 2023 Dec; 195(49):E1709-E1717. PubMed ID: 38110219
[TBL] [Abstract][Full Text] [Related]
19. Perceived social support in patients with chronic pain with and without opioid use disorder and role of medication for opioid use disorder.
Benville JR; Compton P; Giordano NA; Cheatle MD
Drug Alcohol Depend; 2021 Apr; 221():108619. PubMed ID: 33667781
[TBL] [Abstract][Full Text] [Related]
20. A qualitative analysis of barriers to opioid agonist treatment for racial/ethnic minoritized populations.
Husain JM; Cromartie D; Fitzelle-Jones E; Brochier A; Borba CPC; Montalvo C
J Subst Abuse Treat; 2023 Jan; 144():108918. PubMed ID: 36403456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
